SCLN Financial Facts
Provision for income tax: 534KBasic net income per share: 0.06
See Full Income Statement
Commitments and contingencies: 0
Accrued and other current liabilities: 21.43M
See Full Balance Sheet
Earnings History for SciClone Pharmaceuticals, Inc. (SCLN)
|
Expand Research on SCLN
| Next EPS Date | 7/1/13 *Est. | EPS Growth Rate | N/A |
|---|---|---|---|
| Average EPS % Beat Rate | -13.1% | Revenue Growth Rate | N/A |
| Average % Move 1-Wk after EPS | -6.4% |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Estimize EPS/Revs | Gd. | % Since | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 5/10/11 | Q111 | $0.08 | $0.10 | -$0.02 | $21.7M | $24.32M | N/A / N/A | = | +6.8% | Details | |
| 8/9/11 | Q211 | $0.13 | $0.10 | +$0.03 | $33.1M | $33.36M | N/A / N/A | = | -14% | Details | |
| 3/31/11 | Q111 | $0.08 | $0.11 | -$0.03 | $23.62M | $23.59M | N/A / N/A | = | +20.5% | Details | |
4/1/13  |
 |
Q413 | $0.04 | $0.12 | -$0.08 | $33.1M | $35.3M | N/A / N/A | N/A | +5.4% | Details |
| 3/13/12 |
|
Q411 | $0.20 | $0.12 | +$0.08 | $41.4M | $40.39M | N/A / N/A |  |
-6.7% | Details |
| 5/9/12 | Q112 | $0.15 | $0.14 | +$0.01 | $39.2M | $37.08M | N/A / N/A | N/A | -17.2% | Details | |
| 11/8/11 |
|
Q311 | $0.17 | $0.15 | +$0.02 | $37.4M | $37.5M | N/A / N/A | = | +11.7% | Details |
| 8/8/12 |
|
Q212 | $0.19 | $0.17 | +$0.02 | $40.3M | $41.98M | N/A / N/A | |
-4.5% | Details |
